Med24
metabolic-therapy 19. 10. 2026 • 2 min read • Journal of global health (PubMed)

Associations of cumulative exposure and dynamic trajectories of the combined atherogenic-frailty index with incident cardiometabolic multimorbidity: a prospective cohort study.

BACKGROUND: Cardiometabolic multimorbidity (CMM) poses a growing global health burden, yet effective tools for early risk stratification remain limited. The combined impact of atherogenic dyslipidaemia and physiological frailty, captured by the atherogenic index of plasma-frailty index (AIP-FI), on CMM development is...

Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID)

This prospective cohort study investigated the relationship between the combined atherogenic-frailty index (AIP-FI) and the development of cardiometabolic multimorbidity (CMM). The research included 4,157 participants aged 45 years and older without existing CMM from CHARLS.

Key Clinical Findings

Over an 8.5-year follow-up, 612 incident CMM cases were observed. Higher baseline and cumulative AIP-FI levels were significantly associated with increased CMM risk. Cumulative exposure demonstrated a stronger effect on risk, with a hazard ratio of 1.46 per standard deviation increment (95% CI: 1.38-1.54). Individuals in the highest quartile of cumulative AIP-FI exhibited a near four-fold higher CMM risk compared to those in the lowest quartile (HR = 3.95; 95% CI = 2.95-5.29). Clustering analyses indicated that groups with high-stable AIP-FI displayed the highest CMM risks. The use of cumulative AIP-FI improved predictive performance for CMM (AUC = 71.17%) and significantly enhanced risk reclassification compared to traditional markers.

Sponsored content

Study Implications

Mediation analyses suggested bidirectional synergistic effects between AIP and FI. This study highlights the importance of monitoring the cumulative burden and dynamic trajectories of

Original Scientific Source
Journal of global health (PubMed)
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.
metabolic-therapy

Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.

Insulin resistance is an important metabolic derangement contributing to the pathogenesis of type 2 diabetes, obesity, metabolic syndrome, and other chronic diseases, underlining the requirement for techniques that enable in vivo analysis of tissue-specific glucose metabolism. 18F-fluorodeoxyglucose positron emission...

10. 11. 2026 Read article →
Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.
metabolic-therapy

Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.

BACKGROUND: Although body mass index (BMI) is widely used to assess obesity-related health risks, it may fail to detect individuals with normal weight who present with significant cardiometabolic abnormalities. This phenotype, often overlooked in clinical practice, is associated with increased risk of cardiovascular...

30. 10. 2026 Read article →
Advertisement